A Unique Case of Hepatocellular Carcinoma Treated with Radiofrequency Ablation with More than 12 Years Overall Survival: A Case Report
2010

Long-term Survival After Radiofrequency Ablation for Liver Cancer

Sample size: 1 publication Evidence: low

Author Information

Author(s): Thanos Loukas, Ptohis Nikolaos, Pomoni Anastasia, Sotiropoulou Evangelia, Pomoni Maria, Kelekis Dimitrios

Primary Institution: Department of Computed Tomography and Interventional Radiology, “Sotiria” General Hospital of Chest Diseases

Hypothesis

Can radiofrequency ablation (RFA) provide long-term survival benefits for patients with hepatocellular carcinoma (HCC)?

Conclusion

The patient treated with RFA for HCC survived more than 12 years and maintained excellent clinical status.

Supporting Evidence

  • The patient had a single lesion and was initially a suitable candidate for surgical resection.
  • RFA was performed three times over 12 years due to tumor progression and recurrence.
  • Post-treatment, the patient's AFP levels normalized and remained stable for years.

Takeaway

A 72-year-old man with liver cancer was treated with a special heat technique called radiofrequency ablation, and he lived for over 12 years after the treatment.

Methodology

The patient underwent radiofrequency ablation (RFA) under local anesthesia, with follow-up imaging to assess treatment response.

Limitations

The study is based on a single case report, limiting generalizability.

Participant Demographics

One 72-year-old male patient with cirrhosis related to hepatitis C.

Digital Object Identifier (DOI)

10.1155/2010/151846

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication